Joint ESMO-ESTRO symposium tackles brain metastases
Joint ESMO-ESTRO symposium explored innovative approaches to the treatment of brain metastases, including prevention in patients with primary cancers, treating patients with human epidermal growth factor 2 (HER2)-positive metastatic breast cancer (MBC) and brain metastases with the combination of lapatinib and capecitabine, and the potential for radiation dose escalation.